Harmony Biosciences Holdings (HRMY) Other Operating Expenses (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Other Operating Expenses data on file, last reported at $31.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 3.2% year-over-year to $31.7 million; the trailing twelve-month figure through Mar 2026 stood at $161.3 million (up 35.27% YoY), and the FY2025 full-year result was $189.6 million, up 30.01% from the prior year.
• Other Operating Expenses slipped to $31.7 million in Q1 2026, from $49.9 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $51.6 million in Q4 2023 to a low of $7.6 million in Q1 2022.
• A 5-year average of $28.5 million and a median of $28.5 million in 2024 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slumped 51.13% in 2022 and surged 411.76% in 2023, its largest moves.
• Tracing HRMY's Other Operating Expenses over 5 years: stood at $10.1 million in 2022, then surged by 411.76% to $51.6 million in 2023, then slumped by 32.88% to $34.7 million in 2024, then soared by 44.04% to $49.9 million in 2025, then tumbled by 36.53% to $31.7 million in 2026.
• Business Quant data shows HRMY's Other Operating Expenses at $31.7 million in Q1 2026, $49.9 million in Q4 2025, and $29.5 million in Q3 2025.